Publication
Helicobacter Pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016
dc.contributor.author | Kori, M | |
dc.contributor.author | Le Thi, TG | |
dc.contributor.author | Werkstetter, K | |
dc.contributor.author | Sustmann, A | |
dc.contributor.author | Bontems, P | |
dc.contributor.author | Lopes, AI | |
dc.contributor.author | Oleastro, M | |
dc.contributor.author | Iwanczak, B | |
dc.contributor.author | Kalach, N | |
dc.contributor.author | Misak, Z | |
dc.contributor.author | Cabral, J | |
dc.contributor.author | Homan, M | |
dc.contributor.author | Cilleruelo Pascual, ML | |
dc.contributor.author | Pehlivanoglu, E | |
dc.contributor.author | Casswall, T | |
dc.contributor.author | Urruzuno, P | |
dc.contributor.author | Martinez Gomez, MJ | |
dc.contributor.author | Papadopoulou, A | |
dc.contributor.author | Roma, E | |
dc.contributor.author | Dolinsek, J | |
dc.contributor.author | Rogalidou, M | |
dc.contributor.author | Urbonas, V | |
dc.contributor.author | Chong, S | |
dc.contributor.author | Kindermann, A | |
dc.contributor.author | Miele, E | |
dc.contributor.author | Rea, F | |
dc.contributor.author | Cseh, A | |
dc.contributor.author | Koletzko, S | |
dc.date.accessioned | 2021-06-24T09:09:17Z | |
dc.date.available | 2021-06-24T09:09:17Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Objectives: The aim of the study was to assess clinical presentation, endoscopic findings, antibiotic susceptibility and treatment success of Helicobacter pylori (H. pylori) infected pediatric patients. Methods: Between 2013 and 2016, 23 pediatric hospitals from 17 countries prospectively submitted data on consecutive H. pylori-infected (culture positive) patients to the EuroPedHP-Registry. Results: Of 1333 patients recruited (55.1% girls, median age 12.6 years), 1168 (87.6%) were therapy naïve (group A) and 165 (12.4%) had failed treatment (group B). Patients resided in North/Western (29.6%), Southern (34.1%) and Eastern Europe (23.0%), or Israel/Turkey (13.4%). Main indications for endoscopy were abdominal pain or dyspepsia (81.2%, 1078/1328). Antral nodularity was reported in 77.8% (1031/1326) of patients, gastric or duodenal ulcers and erosions in 5.1% and 12.8%, respectively. Primary resistance to clarithromycin (CLA) and metronidazole (MET) occurred in 25% and 21%, respectively, and increased after failed therapy. Bacterial strains were fully susceptible in 60.5% of group A, but in only 27.4% of group B. Primary CLA resistance was higher in Southern and Eastern Europe (adjusted odds ratio [ORadj] = 3.44, 95% confidence interval [CI] 2.22-5.32, P < 0.001 and 2.62, 95% CI: 1.63-4.22, P < 0.001, respectively) compared with Northern/Western Europe. Children born outside Europe showed higher primary MET resistance (ORadj = 3.81, 95% CI: 2.25-6.45, P < 0.001). Treatment success in group A reached only 79.8% (568/712) with 7 to 14 days triple therapy tailored to antibiotic susceptibility. Conclusions: Peptic ulcers are rare in dyspeptic H. pylori-infected children. Primary resistance to CLA and MET is markedly dependent on geographical regions of birth and residence. The ongoing survey will show whether implementation of the updated ESPGHAN/NASPGHAN guidelines will improve the eradication success. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | J Pediatr Gastroenterol Nutr. 2020;71(4):476-483 | pt_PT |
dc.identifier.doi | 10.1097/MPG.0000000000002816 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/3749 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wolters Kluwer Health | pt_PT |
dc.subject | Amoxicillin | pt_PT |
dc.subject | Anti-Bacterial Agents | pt_PT |
dc.subject | Child | pt_PT |
dc.subject | Clarithromycin | pt_PT |
dc.subject | Drug Therapy, Combination | pt_PT |
dc.subject | Europe | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Israel | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Metronidazole | pt_PT |
dc.subject | Registries | pt_PT |
dc.subject | Turkey | pt_PT |
dc.subject | Helicobacter Infections | pt_PT |
dc.subject | Helicobacter pylori | pt_PT |
dc.subject | HDE GAS PED | pt_PT |
dc.title | Helicobacter Pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016 | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 483 | pt_PT |
oaire.citation.issue | 4 | pt_PT |
oaire.citation.startPage | 476 | pt_PT |
oaire.citation.title | Journal of pediatric gastroenterology and nutrition | pt_PT |
oaire.citation.volume | 71 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- J Ped Gastroenterol Nutr 2020_71_76.pdf
- Size:
- 193.2 KB
- Format:
- Adobe Portable Document Format
- Description: